Premium
Patients with chronic urticaria have a higher risk of psychiatric disorders: a population‐based study
Author(s) -
Chu C.Y.,
Cho Y.T.,
Jiang J.H.,
Chang C.C.,
Liao S.C.,
Tang C.H.
Publication year - 2020
Publication title -
british journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.304
H-Index - 179
eISSN - 1365-2133
pISSN - 0007-0963
DOI - 10.1111/bjd.18754
Subject(s) - medicine , psychiatry , population , medical prescription , epidemiology of child psychiatric disorders , disease , environmental health , pharmacology
Summary Chronic urticaria (CU) is a skin disease which causes itchy hives that last for at least six weeks. It is a common disease that affects 0.6 to 0.8% of the general population worldwide. CU can affect people's quality of life, performance at school, and work. Although a few recent studies have investigated the association of psychiatric disorders and urticaria, the relative risk of various psychiatric disorders and the usage of psychiatric medications among CU patients in a large population is largely unknown. In this study, the authors aimed to investigate the prevalence (how common it is) and relative risks of psychiatric disorders or psychiatric medication use among CU patients by CU severity level. This is a population‐based study from Taiwan. The authors found that CU patients had a 1.43‐fold to 2.32‐fold higher risk of psychiatric disorders, and had more frequent psychiatric medication prescription, compared to the general population. The authors concluded that mental health evaluations and management are important elements in CU management. This summary relates to the study: Patients with chronic urticaria have a higher risk of psychiatric disorders: a population‐based study